Table 1.
Main characteristics of patients according to treatment group before and after matching or weighting
|
Median [Q1-Q3] |
Allo-SCT |
Controls |
p-value |
|---|---|---|---|
|
N (%) |
|
|
|
|
MM |
|
|
|
| Original set | n=23 | n=142 | |
| Age |
48 [40.5-51] |
51.5
[47-55] |
0.005 |
| Beta2 ≥ 3.5 |
4 (17 %) |
52 (37 %) |
0.12 |
| Months to relapse |
16 [11–32.5] |
26.5
[17-38] |
0.014 |
| Matched set |
n=21 |
n=21 |
|
| Age |
49
[41-51] |
46
[42-50] |
0.24 |
| Beta2 ≥ 3.5 |
4 (19 %) |
4 (19 %) |
0.71 |
| Months to relapse |
17
[13-33] |
24
[17-32] |
0.22 |
|
Weighted set |
n=268 |
n=165 |
|
| Age |
56
[51-58] |
51
[46-54] |
0.15 |
| Beta2 ≥ 3.5 |
4 (19%) |
4 (19%) |
0.28 |
| Months to relapse |
58 [26–70] |
25
[17-36] |
0.08 |
|
FL |
|
|
|
|
Original set |
n=28 |
n=115 |
|
| Age |
38
[33-42] |
46
[40-52] |
0.0001 |
| No previous regimens |
4
[3,4] |
3
[2-4] |
0.005 |
| Months to relapse |
6.7 [5.6-9.2] |
4.6 [3.7-6.1] |
0.0001 |
|
Matched set |
n=19 |
n=19 |
|
| Age |
38
[33-42] |
38
[33-45] |
0.35 |
| No previous regimens |
3
[3,4] |
3
[3,4] |
0.90 |
| Months to relapse |
6.3 [4.7-8.9] |
7.8 [4.0-10.7] |
0.82 |
|
Weighted set |
n=78 |
n=117 |
|
| Age |
39
[35-46] |
44
[34-50] |
0.42 |
| No previous regimens |
3
[3,4] |
3
[2-4] |
0.16 |
| Months to relapse |
5.9 [4.7-7.4] |
5.3 [3.8-9.3] |
0.03 |
|
Hodgkin disease |
|
|
|
|
Original set |
n=23 |
n=19 |
|
| Age |
23
[19-29] |
29
[24-35] |
0.05 |
| No previous regimens |
4
[3,4] |
4
[4,5] |
0.05 |
| Months to relapse |
1.2 [0–9.2] |
2.4 [0–7.2] |
0.94 |
|
Matched set |
n=15 |
n=15 |
|
| Age |
24
[21-31] |
25
[23-30] |
0.98 |
| No previous regimens |
3
[3,4] |
4
[4,5] |
0.21 |
| Months to relapse |
1.9 [0.3-9.9] |
1.8 [0–5.4] |
0.49 |
|
Weighted set |
n=41 |
n=40 |
|
| Age |
26
[20-49] |
25
[20-32] |
0.71 |
| No previous regimens |
3
[3,4] |
4
[4] |
0.17 |
| Months to relapse | 0.1 [0–0.7] | 0.1 [0–0.5] | 0.35 |